Back to Search
BARBARA LONG, MD MPH
MD MPH
Pediatric Adolescent Medicine Physician
NPI: 1639100902Individual
Specialties, Licenses & Credentials
Pediatrics Physician
Pediatrics
Code: 208000000X
G65750(CA)
Pediatric Sports Medicine Physician
Pediatrics — Sports Medicine
Code: 2080S0010X
G65750(CA)
Pediatric Adolescent Medicine PhysicianPrimary
Pediatrics — Adolescent Medicine
Code: 2080A0000X
MD126297(OR)
Research & Publications (20)
Expanding your use of silicone hydrogel contact lenses: using lotrafilcon A for daily wear.
PMID 19265325·Eye Contact Lens·2009
4-observational
Synthesis, characterization and in vitro antiproliferative activities of new 13-cis-retinoyl ferrocene derivatives.
PMID 19231037·Eur J Med Chem·2009
8-other
Multidirectional sorting modes in deterministic lateral displacement devices.
PMID 18999523·Phys Rev E Stat Nonlin Soft Matter Phys·2008
8-other
Elevated frequency of gamma interferon-producing NK cells in healthy adults vaccinated against influenza virus.
PMID 18003818·Clin Vaccine Immunol·2008
8-other
Conferral of enhanced natural killer cell function by KIR3DS1 in early human immunodeficiency virus type 1 infection.
PMID 18305035·J Virol·2008
8-other
Analysis of carboxysomes from Synechococcus PCC7942 reveals multiple Rubisco complexes with carboxysomal proteins CcmM and CcaA.
PMID 17675289·J Biol Chem·2007
8-other
Distribution of GATA86C08, GATA158G03, D11S2001 alleles in Chinese population sample.
PMID 16882251·J Forensic Sci·2006
8-other
The clinical performance of a silicone hydrogel lens for daily wear in an Asian population.
PMID 16538125·Eye Contact Lens·2006
4-observational
Lymphopenia-driven CD8(+) T cells are resistant to antigen-induced tolerance in NOD.scid mice.
PMID 16821236·Eur J Immunol·2006
7-preclinical
Three-year follow-up of biomicroscopy signs and refractive status in patients wearing lotrafilcon A lenses.
PMID 16284505·Eye Contact Lens·2005
3-trial
Therapeutic strategies using the aromatase inhibitor letrozole and tamoxifen in a breast cancer model.
PMID 15026471·J Natl Cancer Inst·2004
7-preclinical
Discovery of antitumor indolocarbazoles: rebeccamycin, NSC 655649, and fluoroindolocarbazoles.
PMID 12678746·Curr Med Chem Anticancer Agents·2002
6-review
The effect of second-line antiestrogen therapy on breast tumor growth after first-line treatment with the aromatase inhibitor letrozole: long-term studies using the intratumoral aromatase postmenopausal breast cancer model.
PMID 12114443·Clin Cancer Res·2002
7-preclinical
Cellular microcystin content in N-limited Microcystis aeruginosa can be predicted from growth rate.
PMID 11133456·Appl Environ Microbiol·2001
8-other
Antiandrogenic effects of novel androgen synthesis inhibitors on hormone-dependent prostate cancer.
PMID 11118046·Cancer Res·2000
4-observational
Comparison of subjective grading of limbal redness by eyecare practitioners in three countries.
PMID 19474752·Eye Contact Lens·2009
4-observational
HIV-1-specific T Cell-dependent natural killer (NK) cell activation: major contribution by NK cells to interferon-gamma production in response to HIV-1 antigens.
PMID 19500013·AIDS Res Hum Retroviruses·2009
8-other
Continuous and intermittent dosing of lonafarnib potentiates the therapeutic efficacy of docetaxel on preclinical human prostate cancer models.
PMID 19530253·Int J Cancer·2009
7-preclinical
Fundamental optical properties of linear and cyclic alkanes: VUV absorbance and index of refraction.
PMID 19630422·J Phys Chem A·2009
8-other
Single particle quantum dot imaging achieves ultrasensitive detection capabilities for Western immunoblot analysis.
PMID 19453141·ACS Nano·2009
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 2055 NW SAVIER ST, SUITE 201
PORTLAND, OR 97209 - Phone
- (503) 494-1414
Quick Facts
- NPI
- 1639100902
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Not confirmed
- Specialties
- 3
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile